3 Medical Routines That Older People May Not Need - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

3 Medical Routines That Older People May Not Need

“The treatment may be more burdensome than the condition itself."

  • By

  • Paula Span

  • May 22, 2026

  • 8 min

Share

Objective:

To explore medical screenings and treatments that may be unnecessary for older adults, based on recent research.

Key Findings:
  • The benefits of repeat colonoscopies after age 75 are minimal, and risks may outweigh benefits.
  • Actinic keratoses have a low risk of progressing to skin cancer, and treatment may be more burdensome than the condition.
  • Many older adults with subclinical hypothyroidism may not need lifelong levothyroxine treatment, and some can safely discontinue it.
Interpretation:

The risks and benefits of common medical procedures and treatments change with age, leading to reconsideration of their necessity.

Limitations:
  • The findings may not apply universally to all older patients, as individual health conditions vary.
  • Further research is needed to establish clear guidelines for discontinuing treatments and screenings.
Conclusion:

Reevaluation of medical routines for older adults is essential to avoid unnecessary procedures and treatments.

Original Source(s)

3 Medical Routines That Older People May Not Need

  • by Paula Span

  • May 22, 2026

Related Content

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

300K settlement follows unlawful prescribing claims

The federal settlement resolves allegations of unlawful controlled substance prescribing and absent patient records and restricts future DEA registration for certain controlled substances.

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.